Syrrx, Inc. Awarded ATP Grant To Pursue High-Throughput Crystallization Of Membrane Proteins Using Heterogenous Nucleants
10/19/2005 5:11:11 PM
Syrrx Inc., a next generation structure-based drug discovery company, today announced the receipt of an Advanced Technology Program (ATP) grant to facilitate the development of nanoscale arrays and processes that improve the crystallization of medically important proteins, facilitating investigation of these proteins as possible targets for the design of new medicines.
comments powered by